Yunqi Liao

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

Yunqi Liao is an author at Uppsala University specializing in pharmacodynamics of anticancer agents, human epidermal growth factor receptor 2-targeted therapy, and tumor uptake mechanisms.

ORCID

Publications per year

2024–2024

Publications

Half-life extension via ABD-fusion leads to higher tumor uptake of an affibody-drug conjugate compared to PAS- and XTENylation.

Jie Zhang, Vitalina Bodenko, M. S. Larkina et al. · Journal of Controlled Release · 2024 · 12 citations · Full text

Medicine, Oncology, Pharmacology +17

Evaluation of a novel 177Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profile

Yongsheng Liu, Maryam Oroujeni, Yunqi Liao et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2024 · 11 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

1–2 of 2